Tci Wealth Advisors, Inc. Alaunos Therapeutics, Inc. Call Options Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 02, 2018	SELL	$2.26 - $3.27 $677 - $981	-300 Reduced 75.0%	100 $0
Q1 2018 Apr 30, 2018	BUY	$3.46 - $5.14 $346 - $514	100 Added 33.33%	400 $1,000
Q4 2017 Feb 01, 2018	BUY	$4.0 - $6.54 $400 - $654	100 Added 50.0%	300 $1,000
Q3 2017 Oct 24, 2017	BUY	$4.99 - $6.57 $998 - $1,314	200	200 $1,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.